CMS certification 330214
NYU Langone Hospitals
550 First Avenue, New York, NY 10016
NYU Langone Hospitals has a CMS overall rating of 5 out of 5 stars. 75% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 21 and worse on 3. Emergency patients spend a median of 3 h 23 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 10,034 completed surveys, 23% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | NY | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 836 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 23 min | 3 h 14 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 22 visits sampled | 4 h 52 min | 4 h 54 min | 4 h 17 min |
| Left before being seen Lower is better · 352,950 patients | 1% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 21 patients | 95% | 67% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 187 patients | 83% | 60% | 65% |
How NYU Langone Hospitals compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| NYU Langone HospitalsThis hospital | 5/5 | 75% | 3 h 23 min | 21 better 3 worse |
| Bellevue Hospital CenterSame city | 2/5 | 65% | 3 h 1 min | 2 better 2 worse |
| Mount Sinai WestSame city | 4/5 | 62% | 4 h 32 min | 7 better 3 worse |
| Hospital for Special SurgerySame city | 5/5 | 87% | — | 5 better |
| VA New York Harbor Healthcare System - Ny Div.Same city | 3/5 | 65% | — | 1 better 2 worse |
| Metropolitan Hospital CenterSame city | 3/5 | 64% | 2 h 51 min | 3 better |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in New York.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 23,286 cases | Too few cases | 1.6% | 3.9% |
| Heart attack 547 cases | Too few cases | 6.7% | 11.9% |
| Heart failure 2,910 cases | Too few cases | 5.2% | 11.1% |
| Pneumonia 4,115 cases | Too few cases | 8% | 15.2% |
| Stroke 1,351 cases | Too few cases | 7.4% | 11.9% |
| COPD 532 cases | Too few cases | 5.2% | 8.6% |
| Heart bypass surgery (CABG) 331 cases | Too few cases | 1.1% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | Better | 0.67 likely 0.56 – 0.78 | 1 |
| After hip or knee replacement 3,298 cases | Too few cases | 2.8% | 4.1% |
| Deaths after a serious but treatable surgical complication 561 cases | Better | 110.18 per 1,000 likely 84.1 per 1,000 – 136.26 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 40,829 cases | No different | 0.6 per 1,000 likely 0.38 per 1,000 – 0.82 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 48,461 cases | No different | 0.13 per 1,000 likely 0.01 per 1,000 – 0.24 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 50,693 cases | No different | 0.23 per 1,000 likely 0.12 per 1,000 – 0.34 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 12,979 cases | No different | 1.79 per 1,000 likely 0.99 per 1,000 – 2.59 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 9,390 cases | No different | 1.38 per 1,000 likely 0.66 per 1,000 – 2.11 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 9,218 cases | Better | 3.24 per 1,000 likely 1.36 per 1,000 – 5.12 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 16,112 cases | Better | 2.66 per 1,000 likely 1.81 per 1,000 – 3.51 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 9,540 cases | Better | 2.56 per 1,000 likely 1.28 per 1,000 – 3.83 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 3,510 cases | No different | 1.62 per 1,000 likely 0.53 per 1,000 – 2.72 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 9,995 cases | No different | 1.48 per 1,000 likely 0.95 per 1,000 – 2.01 per 1,000 | 1.06 per 1,000 |
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.39 likely 0.26 – 0.56 | 1 |
| Urinary tract infections from catheters (CAUTI) | Better | 0.29 likely 0.18 – 0.45 | 1 |
| Surgical site infections after colon surgery | No different | 0.86 likely 0.6 – 1.2 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 1.09 likely 0.48 – 2.16 | 1 |
| MRSA bloodstream infections | Better | 0.53 likely 0.33 – 0.81 | 1 |
| C. diff intestinal infections | Better | 0.1 likely 0.06 – 0.14 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 667 cases | Too few cases | 13.3% | 14.4% |
| Readmitted after heart failure 4,060 cases | Too few cases | 18.7% | 21.3% |
| Readmitted after pneumonia 5,069 cases | Too few cases | 16.4% | 17.3% |
| Readmitted after COPD 820 cases | Too few cases | 19.7% | 20% |
| Readmitted after heart bypass surgery 386 cases | Too few cases | 6.8% | 11% |
| Readmitted after hip or knee replacement 3,383 cases | Too few cases | 3.7% | 5.8% |
| Days back in hospital after a heart attack 603 cases | Too few cases | -23.8 days per 100 | — |
| Days back in hospital after heart failure 3,334 cases | Too few cases | -22.8 days per 100 | — |
| Days back in hospital after pneumonia 4,338 cases | Too few cases | -0.5 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 10,521 cases | Better | 10.5 per 1,000 likely 9.1 per 1,000 – 12.3 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 2,678 cases | Worse | 11.9 per 100 likely 10.8 per 100 – 13.2 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 2,678 cases | Better | 3.7 per 100 likely 3.1 per 100 – 4.4 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 6,063 cases | Better | 0.7 likely 0.7 – 0.8 | — |
1 more measure had too few cases here to report.
Clinicians registered at this address
92 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry, plus 50 residents and trainees. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Anesthesiology | 13 |
| Psychiatry | 9 |
| Internal Medicine | 8 |
| Hospitalist | 6 |
| Dermatology | 4 |
| Acute Care | 3 |
| Anatomic Pathology & Clinical Pathology | 3 |
| Diagnostic Radiology | 3 |
| Emergency Medicine | 3 |
| Physician Assistant | 3 |
| Hospice and Palliative Medicine | 2 |
| Neurology | 2 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $185,974
- 2020 $761,850
- 2021 $277,550
- 2022 $2.2M
- 2023 $2.7M
- 2024 $1.7M
- 2025 $3.8M
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Space rental and facility fees | $109,890 | 19 |
| Debt forgiveness | $59,229 | 13 |
| Gifts | $58,350 | 1 |
| Royalties and licensing fees | $48,918 | 4 |
| Medical devices and supplies on long-term loan | $32,175 | 20 |
| Grants | $21,000 | 3 |
| Speaking, teaching and other services | $1,375 | 5 |
| Education | $469 | 8 |
| Food and beverage | $431 | 1 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. | $2.9M | 71 |
| Collegium Pharmaceutical, Inc. | $242,466 | 6 |
| Alnylam Pharmaceuticals Inc. | $128,904 | 6 |
| Shockwave Medical, Inc | $111,252 | 53 |
| Philips North America LLC | $106,250 | 3 |
| Scientia Vascular | $58,350 | 1 |
| Karyopharm Therapeutics Inc. | $51,878 | 39 |
| United Imaging Healthcare North America, Inc. | $47,500 | 2 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Randomized Phase 2 Trial of Fruquintinib and TAS-102 as Compared to Fruquintinib in Patients With Refractory Advanced/Metastatic Colorectal Cancer … Takeda Pharmaceuticals U.S.A., Inc. | $1.3M |
| INNOVATIVE TRIAL FOR UNDERSTANDING THE IMPACT OF TARGETED THERAPIES IN NF2 (INTUITT-NF2) Takeda Pharmaceuticals U.S.A., Inc. | $1.1M |
| A STUDY OF INTRATHECAL SHP611 IN PARTICIPANTS WITH LATE INFANTILE METACHROMATIC LEUKODYSTROPHY Takeda Pharmaceuticals U.S.A., Inc. · NCT03771898 | $281,785 |
| AN OPEN-LABEL TREATMENT WITH RANDOMIZATION OBESERVATION, INVESTIGATOR- INITIATED STUDY, ON THE DURATION AND EFFICACY OF JORNAY PM (METHYLPHENIDATE HY… Collegium Pharmaceutical, Inc. | $242,466 |
| NYU-007: Quantitative MR biomarker development for GBM during Unity radiotherapy Philips North America LLC | $106,250 |
| Autonomic dysfunction and peripheral neuropa-thy in patients with cardiac ATTR amyloidosis Alnylam Pharmaceuticals Inc. | $72,904 |
| Prospective, Multicenter, Single-Arm, Investigational Device Exemption (IDE) Study of the Shockwave Intravascular Lithotripsy (IVL) System With the S… Shockwave Medical, Inc | $61,830 |
| A Phase 3, Randomized, Placebo-Controlled, Double-Blind, Multicenter Trial of Selinexor in Maintenance Therapy After Systemic Therapy for Patients Wi… Karyopharm Therapeutics Inc. | $51,878 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about NYU Langone Hospitals
Is NYU Langone Hospitals a good hospital?
NYU Langone Hospitals has a CMS overall rating of 5 out of 5 stars. Of the 27 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 21 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend NYU Langone Hospitals?
75% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 10,034 completed HCAHPS surveys.
How long is the wait in the NYU Langone Hospitals emergency room?
Emergency patients spend a median of 3 h 23 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 1% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does NYU Langone Hospitals receive money from drug and device companies?
Drug and device makers reported $3.8M in payments to NYU Langone Hospitals for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.